NCT00816764View on ClinicalTrials.gov

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
CarcinomaOvarian CancerOvarian DiseasesOvarian Neoplasms
Interventions
BIOLOGICAL

AGS-8M4

IV Infusion

Trial Locations (3)

10021

New York

10032

New York

19111

Baltimore

Sponsors

Collaborators (1)

Agensys, Inc.
All Listed Sponsors
collaborator

Agensys, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY